NYSE:COR

Cencora Stock Insider Trading

> Medical - Distribution

Buy COR

*Your capital is at risk

$311.34

-0.89 (-0.285%)

At Close: Jul 31, 2026

Cencora Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at -5.17. In total, the insiders bought 382.97M and sold 125.13K COR shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	-5.17
● Buy	382.97M shares
● Sell	125.13K shares
73% Buy Activity Moderate Positive Correlation
Buy Signal Low Confidence Jun 29, 2026 Analysis Breakdown: Weakened by a contradictory negative Insider Power Score. Partially supported by a positive historical correlation. Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date	Type	Person	Role	Amount
Nov 20, 2025 Sell	Common Stock F-InKind	Mauch Robert P. President & CEO	CEO / President	2 144 Value: $776.3K
Nov 20, 2025 Buy	Common Stock M-Exempt	Mauch Robert P. President & CEO	CEO / President	5 790 Value: $2.10M
Nov 20, 2025 Buy	Common Stock M-Exempt	Cleary James F Chief Financial Officer	C-Suite Officer	1 876 Value: $679.2K
Nov 20, 2025 Sell	Common Stock F-InKind	Cleary James F Chief Financial Officer	C-Suite Officer	824 Value: $298.3K
Nov 20, 2025 Buy	Restricted Stock Units M-Exempt	Cleary James F Chief Financial Officer	C-Suite Officer	1 876 Value: $679.2K
Nov 20, 2025 Buy	Common Stock M-Exempt	Krikorian Lazarus SVP & Chief Accounting Officer	Officer	1 023 Value: $370.4K
Nov 20, 2025 Sell	Common Stock F-InKind	Krikorian Lazarus SVP & Chief Accounting Officer	Officer	421 Value: $152.4K
Nov 20, 2025 Buy	Restricted Stock Units M-Exempt	Krikorian Lazarus SVP & Chief Accounting Officer	Officer	1 023 Value: $370.4K
Nov 18, 2025 Buy	Common Stock M-Exempt	Mauch Robert P. President & CEO	CEO / President	3 763 Value: $324.0K
Nov 18, 2025 Sell	Common Stock S-Sale	Mauch Robert P. President & CEO	CEO / President	5 096 Value: $1.87M
Nov 18, 2025 Buy	Non-qualified Stock Option (Right to Buy) M-Exempt	Mauch Robert P. President & CEO	CEO / President	3 763 Value: $324.0K
Nov 13, 2025 Sell	Common Stock F-InKind	Krikorian Lazarus SVP & Chief Accounting Officer	Officer	1 059 Value: $331.0K
Nov 13, 2025 Sell	Common Stock F-InKind	Campbell Elizabeth S Executive Vice President	CEO / President	9 532 Value: $2.98M
Nov 13, 2025 Buy	Common Stock A-Award	Campbell Elizabeth S Executive Vice President	CEO / President	20 613 Value: $7.53M
Nov 13, 2025 Buy	Common Stock A-Award	Cleary James F Chief Financial Officer	C-Suite Officer	30 062 Value: $11.0M
Nov 13, 2025 Sell	Common Stock F-InKind	Mauch Robert P. President & CEO	CEO / President	18 677 Value: $5.84M
Nov 13, 2025 Buy	Common Stock A-Award	Mauch Robert P. President & CEO	CEO / President	42 944 Value: $15.7M
Nov 13, 2025 Sell	Common Stock F-InKind	Cleary James F Chief Financial Officer	C-Suite Officer	13 901 Value: $4.34M
Nov 13, 2025 Buy	Common Stock A-Award	Krikorian Lazarus SVP & Chief Accounting Officer	Officer	2 434 Value: $889.5K
Nov 12, 2025 Buy	Restricted Stock Units A-Award	Campbell Elizabeth S Executive Vice President	CEO / President	3 523 Value: $1.28M
Nov 12, 2025 Buy	Restricted Stock Units A-Award	Mauch Robert P. President & CEO	CEO / President	15 960 Value: $5.80M
Nov 12, 2025 Buy	Restricted Stock Units A-Award	Cleary James F Chief Financial Officer	C-Suite Officer	4 733 Value: $1.72M
Nov 12, 2025 Buy	Restricted Stock Units A-Award	Verma Pawan EVP, Chief Data & Info Officer	Officer	3 963 Value: $1.44M
Nov 12, 2025 Buy	Restricted Stock Units A-Award	Krikorian Lazarus SVP & Chief Accounting Officer	Officer	2 271 Value: $825.3K
Sep 30, 2025 Buy	Common Stock	Clyburn Frank Director	Director	0 Value: $0

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT CENCORA INC.

Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S. Healthcare Solutions segment distributes generic and injectable pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alt...

Read Full Profile Here